Understanding and enhancing approaches to quality...

In the News

August CED message is here

Setting smart annual operational objectives The latest monthly message from IHI Chief Executive Director, Dr. Honorati Masanja, is here. This month the director underlines the setting of smart annual operational …

Vacancy: IHI recruits Project Manager for malaria vaccine trials

Vacancy: IHI recruits Project Manager for malaria vaccine trial project in Bagamoyo A clinical trials facility at Kingani in Bagamoyo. Ifakara Health Institute invites applications from suitably qualified candidates to …

Recent Projects

Vaccine Delivery Costing Study

As countries drive towards achieving high and equitable coverage of life-saving vaccines, the availability of sustainable, equitable, and predictable financing for vaccine delivery is essential. Over the last two decades, …

Evaluation of Cepheid GeneXpert Omni combined with the Xpert MTB/RIF Ultra in Primary Health Care in Tanzania

GeneXpert Omni (Omni) is a new developed diagnostic tool with characteristic suitable for use in resource limited settings e.g. portability, battery powered. The GeneXpert Omni is considered the next generation …

This is an evaluation study that IHI is conducting in collaboration with London school of hygiene and tropical medicine. The research takes place in the context of an innovative intervention developed by the international NGO PharmAccess that extends the benefits of clinical standards and stepwise certification to small and medium-sized facilities in LMIC, using standards developed with international accreditation bodies. The PharmAccess model seeks to improve the quality of care that facilities provide, as well as to shape the broader healthcare and finance markets and policy environment. There are several components to the model. Health facilities are assessed on a set of “SafeCare” structural quality standards, trained on quality improvement and business skills, and assisted in the development of a quality and business improvement plan. The evaluation will be a randomised controlled trial to evaluate prospectively the impact on quality of care of the roll out of the PharmAccess model to additional private for-profit and faith-based facilities in Tanzania.

Partners

London School of Hygiene and Tropical Medicine

Funders

Wellcome Trust

Projects Location

A PIXELBASE DESIGN
© Ifakara Health Institute (IHI), 2016